首页> 外文期刊>Fish & Shellfish Immunology >Dissecting the immune pathways stimulated following injection vaccination of rainbow trout (Oncorhynchus mykiss) against enteric redmouth disease (ERM)
【24h】

Dissecting the immune pathways stimulated following injection vaccination of rainbow trout (Oncorhynchus mykiss) against enteric redmouth disease (ERM)

机译:解剖彩虹鳟(Oncorynchus mykiss)注射疫苗接种刺激的免疫途径对肠道红藻(ERM)

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Enteric redmouth disease (ERM or yersiniosis) is one of the most important diseases of salmonids and leads to significant economic losses. It is caused by the Gram-negative bacterium Yersinia ruckeri but can be controlled by bacterin vaccination. The first commercial ERM vaccine was licenced in 1976 and is one of the most significant and successful health practices within the aquaculture industry. Although ERM vaccination provides complete protection, knowledge of the host immune response to the vaccine and the molecular mechanisms that underpin the protection elicited is limited. In this report, we analysed the expression in spleen and gills of a large set of genes encoding for cytokines, acute phase proteins (APPs) and antimicrobial peptides (AMPS) in response to ERM vaccination in rainbow trout, Oncorhynchus mykiss. Many immune genes in teleost fish are known to have multiple paralogues that can show differential responses to ERM vaccination, highlighting the necessity to determine whether all of the genes present react in a similar manner. ERM vaccination immediately activated a balanced inflammatory response with correlated expression of both pro- and anti-inflammatory cytokines (eg IL-1 beta 1-2, TNF-alpha 1-3,IL-6, IL-8 and IL-10A etc.) in the spleen. The increase of pro-inflammatory cytokines may explain the systemic upregulation of APPs (eg serum amyloid A protein and serum amyloid protein P) and AMPs (eg cathelicidins and hepcidin) seen in both spleen and gills. We also observed an upregulation of all the alpha-chains but only one beta-chain (p4082) of the IL-12 family cytokines, that suggests specific IL-12 and IL-23 isoforms with distinct functions might be produced in the spleen of vaccinated fish. Notably the expression of Th1 cytokines (IFN-gamma 1-2) and a Th17 cytokine (IL-17A/F1a) was also up-regulated and correlated with enhanced expression of the IL-12 family alpha-chains, and the majority of pro-and anti-inflammatory cytokines, APPs and AMPs. These expression profiles may suggest that ERM vaccination activates host innate immunity and expression of specific IL-12 and IL-23 isoforms leading to a Th1 and Th17 biased immune response. A late induction of Th2 cytokines (IL-4/13B1-2) was also observed, that may have a homeostatic role and/ or involvement in antibody production. This study has increased our understanding of the host immune response to ERM vaccination and the adaptive pathways involved. The early responses of a set of genes established in this study may provide essential information and function as biomarkers in future vaccine development in aquaculture. (C) 2017 Elsevier Ltd. All rights reserved.
机译:肠道红茅斯病(ERM或YERSINISISIOS)是鲑鱼最重要的疾病之一,导致了重大的经济损失。它是由革兰氏阴性细菌yersinia ruckeri引起的,但可以通过细菌疫苗接种来控制。第一个商业ERM疫苗于1976年获得许可,是水产养殖业中最重要和最成功的健康实践之一。尽管ERM疫苗接种提供完全保护,但对疫苗的宿主免疫反应知识和基于所引出的保护的分子机制有限。在本报告中,我们分析了编码细胞因子,急性期蛋白(APPS)和抗微生物肽(AMPS)的大量基因的脾脏和鳃的表达,以响应虹鳟鱼,oncorhynchus mykiss。已知许多免疫基因在Textost鱼中具有多个副寄生虫,可以显示对ERM疫苗接种的差异反应,突出了确定所有基因是否存在以类似的方式反应的必要性。 ERM接种立即激活具有促炎和抗炎细胞因子的相关表达的平衡炎症反应(例如IL-1β1-2,TNF-α1-3,IL-6,IL-8和IL-10a等。 )在脾脏中。促炎细胞因子的增加可以解释应用的系统性上调(例如血清淀粉样蛋白和血清淀粉样蛋白P)和脾脏和鳃中看到的AMPS(例如Cathelicidins和Hepcidin)。我们还观察到所有α链的上调,但只有一个β-链条(P4082)的IL-12家族细胞因子,表明在接种疫苗的脾脏中可能产生具有不同功能的特异性IL-12和IL-23同种型鱼。值得注意的是,Th1细胞因子(IFN-gamma1-2)和Th17细胞因子(IL-17a / F1a)的表达也上调并与IL-12家族α-链的增强表达相关,以及大多数Pro - 抗炎细胞因子,应用和安培。这些表达谱可能表明ERM接种疫苗接种激活宿主先天免疫和特异性IL-12和IL-23同种型的表达,导致TH1和TH17偏置免疫应答。还观察到Th2细胞因子(IL-4 / 13B1-2)的晚期诱导,这可能具有稳态作用和/或参与抗体产生。本研究提高了我们对ERM疫苗接种的宿主免疫应答以及所涉及的适应途径的理解。在本研究中建立的一组基因的早期反应可以在水产养殖中未来疫苗发育中提供基本信息和功能。 (c)2017 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号